Hansa Biopharma’s Imlifidase Stumbles in Late-Stag...
Category : Clinical Trial Update 18 December 2025Hansa Biopharma has hit a setback in its efforts to expand imlifidase beyond kidney transplantation....
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ionis Kicks Off Phase 3 Angelman Syndrome Trial Wi...
Category : Clinical Trial Update 18 December 2025Ionis Pharmaceuticals is entering a critical phase for its Angelman syndrome program—and it&rs...
Gilead Moves Closer to Filing Novel HIV Combo Afte...
Category : Clinical Trial Update 17 December 2025Gilead Sciences is accelerating toward regulatory submissions for its next-generation HIV treatment...
TempraMed Secures New South Korea Patent for VIVI...
Category : Product Related Updates 17 December 2025TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
Argenx permanently grounds studies of high-flying...
Category : Clinical Trial Update 16 December 2025"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
Latest Newsletter Post
-
Ionis Kicks Off Phase 3 Angelman Sy..
18 December 2025
-
Hansa Biopharma’s Imlifidase Stumbl..
18 December 2025
-
TempraMed Secures New South Korea P..
17 December 2025
-
Gilead Moves Closer to Filing Novel..
17 December 2025
-
Novo’s oral semaglutide edges out C..
16 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com